<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">TOREMIFENE CITRATE</span><br/>(tor-em'i-feen ci'trate)<br/><span class="topboxtradename">Fareston<br/></span><b>Classifications:</b> <span class="classification">antineoplastic</span>; <span class="classification">hormones and synthetic substitutes</span>; <span class="classification">antiestrogen</span><br/><b>Prototype: </b>Tamoxifen<br/><b>Pregnancy Category: </b>D<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>60 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Nonsteroidal antiestrogen chemical derivative of tamoxifen. Antitumor activity thought to be due to ability to compete with
         estrogen for binding sites in the cancer cells.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Depresses tumor growth.</p>
<h1><a name="uses">Uses</a></h1>
<p>Metastatic breast cancer in postmenopausal women who are estrogen receptor positive.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to toremifene; pregnancy (category D).</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Preexisting endometrial hyperplasia; bone metastases (may result in hypercalcemia); geriatric patients; leukopenia and thrombocytopenia;
         liver disease; history of thrombolytic disease; lactation.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Breast Cancer</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 60 mg q.d.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Withhold drug and notify physician if severe hypercalcemia develops.</li>
<li>Store at 15°30° C (59°86° F) in a tightly closed container and protect from light.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> <span class="speceff-common">Hot flashes, sweating,</span> edema. <span class="typehead">CNS:</span> Dizziness. <span class="typehead">GI:</span> <span class="speceff-common">Nausea,</span> vomiting, abnormal liver function tests. <span class="typehead">Respiratory:</span> <span class="speceff-life">Pulmonary embolism</span>. <span class="typehead">Urogenital:</span> <span class="speceff-common">Vaginal discharge,</span> vaginal bleeding. <span class="typehead">Special Senses:</span> Cataracts, dry eyes, corneal keratopathy. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <span class="classification">thiazide diuretics</span> increase risk of hypercalcemia; increased PT on <b>warfarin;</b> <b>carbamazepine,</b> <b>phenobarbital,</b> <b>phenytoin</b> may increase toremifene metabolism. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed from GI tract. <span class="typehead">Peak:</span> 3 h. <span class="typehead">Distribution:</span> &gt;99% protein bound; crosses placenta. <span class="typehead">Metabolism:</span> Metabolized in liver by cytochrome P450 3A4. <span class="typehead">Elimination:</span> Excreted primarily in feces. <span class="typehead">Half-Life:</span> 5 d. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Periodically monitor CBC with differential, serum calcium, liver and kidney functions.</li>
<li>Monitor patients carefully with bone metastases or those on drugs that decrease calcium excretion (e.g., thiazide diuretics)
            for S&amp;S of hypercalcemia (see Appendix F).
         </li>
<li>Monitor PT and INR carefully when given concurrently with warfarin.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report to physician promptly any of the following: Unexplained weakness or fatigue, musculoskeletal pain or calf pain and
            tenderness, sudden chest pain, vaginal bleeding.
         </li>
<li>Schedule periodic eye exams with long-term therapy.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>